Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Theravance Biopharma (TBPH) Other Operating Expenses (2016 - 2024)

Historic Other Operating Expenses for Theravance Biopharma (TBPH) over the last 8 years, with Q3 2024 value amounting to $1.6 million.

  • Theravance Biopharma's Other Operating Expenses changed N/A to $1.6 million in Q3 2024 from the same period last year, while for Jun 2025 it was $1.6 million, marking a year-over-year decrease of 4706.88%. This contributed to the annual value of $4.5 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2024, Theravance Biopharma's Other Operating Expenses is $1.6 million.
  • Theravance Biopharma's 5-year Other Operating Expenses high stood at $3.8 million for Q2 2022, and its period low was -$37.5 million during Q3 2022.
  • Moreover, its 3-year median value for Other Operating Expenses was $1.3 million (2022), whereas its average is -$4.0 million.